OR

ORGANOIDSCIENCES LTD.

Organoid-based platforms for drug testing and regenerative therapeutics.

476040 | KO

Overview

Corporate Details

ISIN(s):
KR7476040001
LEI:
Country:
South Korea
Address:
경기도 성남시 분당구 판교로 338, 6층, 성남시
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

ORGANOIDSCIENCES LTD. is a bio-innovation company specializing in advanced organoid-based technologies for drug development and regenerative medicine. The company focuses on two primary areas: developing novel regenerative therapeutics for diseases that are difficult to treat with conventional methods, and providing organoid-based evaluation platforms for the pharmaceutical industry. Its platforms offer solutions for drug efficacy and toxicity testing, novel material evaluation, and immunotherapy sensitivity analysis (Polaris Platform), serving as a sophisticated alternative to animal testing. By creating three-dimensional cell structures that replicate the function of human organs, ORGANOIDSCIENCES aims to shift the paradigm in therapeutic development and precision medicine.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.4 MB
2025-07-22 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
Korean 64.6 KB
2025-06-30 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 100.3 KB
2025-06-30 00:00
Board/Management Information
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Korean 9.8 KB
2025-06-25 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
Korean 63.6 KB
2025-06-10 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 6.8 KB
2025-05-23 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
Korean 64.7 KB
2025-05-16 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
Korean 71.4 KB
2025-05-16 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
Korean 64.6 KB
2025-05-16 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
Korean 64.6 KB
2025-05-16 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
Korean 68.4 KB
2025-05-16 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
Korean 75.3 KB
2025-05-15 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 108.9 KB
2025-05-15 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.2 KB
2025-05-15 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.1 KB

Automate Your Workflow. Get a real-time feed of all ORGANOIDSCIENCES LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for ORGANOIDSCIENCES LTD.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for ORGANOIDSCIENCES LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

MATCHING SERVICE JAPAN CO.,LTD. Logo
Specialized recruitment firm connecting legal, finance, and accounting experts with top companies.
Japan
6539
Material Group inc. Logo
A professional services firm offering PR consulting, marketing, and brand strategy.
Japan
156A
Medesis Pharma S.A. Logo
Develops therapies for CNS disorders and radiation exposure via a drug delivery platform.
France
ALMDP
Medicofarma Biotech Spolka Akcyjna Logo
A biotech R&D company developing innovative drugs and devices with a focus on oncology therapies.
Poland
MDB
Medpace Holdings, Inc. Logo
Global CRO providing full-service clinical development to biotech, pharma & medical device industries.
United States of America
MEDP
Develops biomarker-based precision therapies for oncology and other incurable diseases.
South Korea
235980
Medrx Co.,Ltd. Logo
Develops and licenses transdermal drug delivery systems for the pharmaceutical industry.
Japan
4586
Developing nanomedicines and drug delivery systems for oncology, hematology, and diagnostics.
Malaysia
N/A
A holding company driving regional growth by supporting construction, HR, and nursing care businesses.
Japan
7369
Mendus Logo
Developing immunotherapies using dendritic cells to prevent cancer recurrence and improve survival.
Sweden
IMMU

Talk to a Data Expert

Have a question? We'll get back to you promptly.